UPDATE ON UNITED THERAPEUTICS $UTHR
This post was just published on ZYX Buy Change Alert. UTHR has announced that it will continue the FREEDOM-EV study of Orenitram extended-release tablets. This is good news. However, many analysts were hoping for better news. A better news would have been if the effectiveness was so good that there would be